openPR Logo
Press release

United States Therapeutic Apheresis Market to Surpass $6 Billion by 2033, Registering 8.5% CAGR | Most Leading Companies - Fresenius SE & Co. KGaA(Fresenius Kabi AG), Terumo Corporation (Terumo BCT Inc.)

11-03-2025 01:22 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Therapeutic Apheresis Market

Therapeutic Apheresis Market

Therapeutic Apheresis Market size was valued at USD 2981.35 million in 2024 and is estimated to reach USD 6009.58 million in 2033 at a compound annual growth rate (CAGR) of 8.50% over the forecast period 2025- 2033.

The Therapeutic Apheresis Market involves blood purification procedures used to treat autoimmune and hematologic disorders. Growth is driven by increasing chronic disease prevalence and technological advancements in plasma separation. Hospitals and specialized clinics are major end-users. Innovations include automated apheresis systems and improved filters. Regulatory support ensures treatment safety and efficacy. Rising demand for personalized and efficient therapeutic options drives market growth.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Therapeutic Apheresis Market Landscape:- https://datamintelligence.com/download-sample/therapeutic-apheresis-market?Ranjith

☛ Therapeutic Apheresis Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In September 2025, Terumo Blood and Cell Technologies launched its Spectra Optia® Apheresis System upgrade, featuring AI-assisted plasma volume monitoring and cloud-based patient data integration to enhance procedural precision and workflow efficiency.

✅ In August 2025, Haemonetics Corporation announced the expansion of its NexSys PCS® platform to include advanced therapeutic apheresis functions for treating neurological and autoimmune diseases such as myasthenia gravis and Guillain-Barré syndrome.

✅ In July 2025, Fresenius Kabi introduced its Amicus Blue® system with improved interface automation for cell separation and plasma exchange therapies in U.S. hospitals and blood centers.

✅ In May 2025, Baxter International Inc. opened a new Apheresis Innovation Center in Illinois, focusing on R&D for selective adsorption columns and personalized plasma therapy devices.

Japan: Recent Industry Developments

✅ In September 2025, Kawasumi Laboratories Inc. launched a compact therapeutic apheresis system designed for bedside plasma exchange and immunoadsorption procedures, targeting smaller hospitals and mobile treatment units.

✅ In August 2025, Asahi Kasei Medical Co., Ltd. expanded production of its PlasmafloTM and Immusorba® filters, driven by increasing global demand for immunotherapy-supportive apheresis procedures.

✅ In July 2025, Toray Medical Co., Ltd. introduced its Toraymyxin® PMX column upgrade for endotoxin removal in septic shock therapy, integrating improved resin binding capacity for higher efficiency.

✅ In June 2025, Kaneka Corporation partnered with Osaka University Hospital to develop selective LDL apheresis membranes for patients with familial hypercholesterolemia and refractory lipid disorders.

☛ Therapeutic Apheresis Market Competitive Landscape:

Fresenius SE & Co. KGaA(Fresenius Kabi AG), Terumo Corporation (Terumo BCT Inc.), Haemonetics Corporation, Cerus Corporation, B. Braun Melsungen AG, Nikkiso Co. Ltd, Medica S.p.A., Sumitomo Bakelite Company Limited (SB-Kawasumi Laboratories, Inc.), Asahi Kasei Corporation(Asahi Kasei Medical Co., Ltd.) and Mallinckrodt Pharmaceuticals(Therakos).

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/therapeutic-apheresis-market?Ranjith

☛ Segments Covered in the Therapeutic Apheresis Market:

By Procedure: Leukapheresis, Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Others

By Application: Hematology, Neurology, Oncology, Nephrology, Others

By Technology: Centrifugation, Membrane filtration

By End-user: Blood banks, Hospitals, Specialty clinics

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Therapeutic Apheresis Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=therapeutic-apheresis-market?Ranjith

☛ Regional Analysis for Therapeutic Apheresis Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Therapeutic Apheresis Market to Surpass $6 Billion by 2033, Registering 8.5% CAGR | Most Leading Companies - Fresenius SE & Co. KGaA(Fresenius Kabi AG), Terumo Corporation (Terumo BCT Inc.) here

News-ID: 4251230 • Views:

More Releases from DataM Intelligence 4market Research LLP

Theranostics Market to Surge to US$ 7.56 Billion by 2033, Fueled by a 15.4% CAGR | GE Healthcare, Jubilant Pharmova Limited (Jubilant Pharma Limited), Theragnostics Ltd.
Theranostics Market to Surge to US$ 7.56 Billion by 2033, Fueled by a 15.4% CAGR …
The global theranostics market reached US$ 2.13 billion in 2023, with a rise to US$ 2.40 billion in 2024, and is expected to reach US$ 7.56 billion by 2033, growing at a CAGR of 15.4% during the forecast period 2025-2033. Key Points: 2024 Market Size: US$ 2.40 Billion 2033 Projected Market Size: US$ 7.56 Billion CAGR (2025-2033): 15.4% North America: Largest market in 2024 Asia Pacific: Fastest-growing market The Theranostics Market integrates therapy and diagnostics to personalize
Telestroke Services Market Hits $1.87 Billion in 2024, Forecast to Reach $5.16 Billion by 2033 | Teladoc Health, Inc., American Well, Eagle Telemedicine.
Telestroke Services Market Hits $1.87 Billion in 2024, Forecast to Reach $5.16 B …
The global telestroke services market size reached US$ 1.87 Billion in 2024 from US$ 1.68 Billion in 2023 and is expected to reach US$ 5.16 Billion by 2033, growing at a CAGR of 12.1% during the forecast period 2025-2033. The Telestroke Services Market offers remote stroke diagnosis and management using telecommunication and imaging technologies. Growth is fueled by increasing stroke prevalence, rural healthcare expansion, and digital health infrastructure. Hospitals, neurology centers,
Smart Medical Devices Market to Reach US$ 180 Billion by 2033, Growing at a 12.8% CAGR | Abbott, Medtronic, F. Hoffmann-La Roche Ltd.
Smart Medical Devices Market to Reach US$ 180 Billion by 2033, Growing at a 12.8 …
The global smart medical devices market size reached US$ 61.66 Billion in 2024 from US$ 55.12 Billion in 2023 and is expected to reach US$ 180.38 Billion by 2033, growing at a CAGR of 12.8% during the forecast period 2025-2033. The Smart Medical Devices Market includes wearable, implantable, and connected devices that monitor and manage patient health. Growth is driven by digital health adoption, chronic disease management, and remote patient monitoring.
Sleep Aids Market to Reach US$ 118.97 Billion by 2033, Growing at 7.8% CAG | Top Companies are Teva Pharmaceutical Industries Ltd., Merck & Co., Sanofi.
Sleep Aids Market to Reach US$ 118.97 Billion by 2033, Growing at 7.8% CAG | Top …
The global sleep aids market reached US$ 60.96billion in 2023, with a rise to US$ 65.20 billion in 2024, and is expected to reach US$ 118.97billion by 2033, growing at a CAGR of 7.8% during the forecast period 2025-2033. Sleep aids refer to substances or devices used to help individuals fall asleep or improve the quality of their sleep. These aids can range from over-the-counter medications, such as antihistamines or melatonin,

All 5 Releases


More Releases for Apheresis

Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing
Apheresis Market Worth $3.9 billion | MarketsandMarkets Trademark
Browse 376 market data Tables and 65 Figures spread through 343 Pages and in-depth TOC on "Apheresis Market by Product (Device (Centrifugation, Membrane Separation) Disposable), Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospital, Blood Collection Center), Region - Global Forecast to 2029 Apheresis Market [https://www.prnewswire.com/news-releases/apheresis-market-worth-3-9-billion--marketsandmarkets-302115226.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a
Apheresis Equipment Market - Efficiency, Safety, Success: Apheresis Equipment Sh …
Newark, New Castle, USA: The "Apheresis Equipment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Apheresis Equipment Market: https://www.growthplusreports.com/report/apheresis-equipment-market/8509 This latest report researches the industry structure, sales, revenue,
Apheresis Equipment Market Report Up to 2031
Visiongain has published a new report on Apheresis Equipment Market Report to 2031. Market is segmented by Product (Disposable apheresis kits, Apheresis machines), by Procedure (Plasmapheresis, Erythrocytaphereswis, Plateletpheresis, Leukapheresis), by Application (Renal diseases, Neurology, Hematology, Others), By Technology (Membrane filtration, Centrifugation). Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed Profiles of Leading Apheresis Equipment Companies. PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of
Apheresis Market Size to Reach Valuation of $4.20 Billion by 2023 | Automated Ap …
Apheresis system assists in the collection and separation of blood components for donation. In addition, this system can perform removal or exchange of blood components for therapeutic procedures. The American National Red Cross offers various therapeutic apheresis services across the U.S. that include plasmapheresis, photopheresis, LDL apheresis, and stem cell harvest. In addition, the center has employed qualified and specialized staff for apheresis procedures while maintaining the accessibility and availability
Apheresis Market (Therapeutic Apheresis & Donor Apheresis): Trends, Opportunitie …
Global Apheresis Market: Overview Apheresis, also known as pheresis and hemapheresis refers to a procedure that comprises extraction of blood from a donor and separating and preserving its components such as leukocytes, platelets, and plasma. Henceforth, the rest of the components are transfused back into the body of the donor. In this process, several abnormal components are also removed from the blood. The apheresis market is categorized from both the therapeutic